Dr. Claus Georg Krenn is the senior physician of an intensive care unit and research group leader of the Department of Anesthesiology and General Intensive Care Medicine at the Medical University of Vienna (MedUni Wien).

Key areas of his teaching and research include hemodynamic monitoring, liver failure, transplantations and organ replacements, acute pulmonary failure, and sepsis.

He completed his residency at the University of Uppsala, Sweden (Prof. G. Hedenstierna).

2001, Post-doc qualification on the subject:
“Clinical value of liver function tests”.

His list of publications includes approximately 90 original works and numerous book contributions.

Dr. Roman Ullrich is senior physician for Intensive Care Medicine at the University Hospital for Anesthesiology at the Medical University of Vienna (MedUni Wien) and director of the lung research group. 1998 – 2000 Fellowship in the Department of Anesthesiology, Massachusetts General Hospital, Harvard Medical University under Dr. Warren M. Zapol, the “father” of extracorporeal membrane oxygenation for treatment of lung failure. 2001 Post-doc qualification on the topic “Innovative Therapeutic Methods in the Treatment of Acute Lung Failure”. The focus of his teaching and research includes treatment of ARDS, new therapeutic methods in ARDS, extracorporeal blood purification methods, and imaging methods for optimization of respiratory therapy.

Dr. Thomas Herndl is a trained attorney
(J.D. Vienna, LL.M Virginia) who is licensed to practice in Austria and New York.

Thomas Herndl has extensive experience in founding and leading corporations; most recently he and two partners established Cato Software Solutions, a software company focused on the prescription and preparation of chemotherapies. He managed the American subsidiary Chemocato LLC for four years.

Under his leadership the company was divested to American multinational corporation BD Becton & Dickinson.

Dr. Claus Georg Krenn is the senior physician of an intensive care unit and research group leader of the Department of Anesthesiology and General Intensive Care Medicine at the Medical University of Vienna (MedUni Wien).

Key areas of his teaching and research include hemodynamic monitoring, liver failure, transplantations and organ replacements, acute pulmonary failure, and sepsis.

He completed his residency at the University of Uppsala, Sweden (Prof. G. Hedenstierna).

2001, Post-doc qualification on the subject: “Clinical value of liver function tests”.

His list of publications includes approximately 90 original works and numerous book contributions.

Dr. Roman Ullrich is senior physician for Intensive Care Medicine at the University Hospital for Anesthesiology at the Medical University of Vienna (MedUni Wien) and director of the lung research group.

1998 – 2000 Fellowship in the Department of Anesthesiology, Massachusetts General Hospital, Harvard Medical University under Dr. Warren M. Zapol, the “father” of extracorporeal membrane oxygenation for treatment of lung failure.

2001 Post-doc qualification on the topic “Innovative Therapeutic Methods in the Treatment of Acute Lung Failure”.

The focus of his teaching and research includes treatment of ARDS, new therapeutic methods in ARDS, extracorporeal blood purification methods, and imaging methods for optimization of respiratory therapy.

Dr. Thomas Herndl is a trained attorney
(J.D. Vienna, LL.M Virginia) who is licensed to practice in Austria and New York.

Thomas Herndl has extensive experience in founding and leading corporations; most recently he and two partners established Cato Software Solutions, a software company focused on the prescription and preparation of chemotherapies. He managed the American subsidiary Chemocato LLC for four years.

Under his leadership the company was divested to American multinational corporation BD Becton & Dickinson.

Martin Schneider is a graduate of TGM Vienna with a major in mechanical engineering and has specialized in project management for many years.

He possesses extensive experience in international financial and organizational management.

In recent years he held leading positions at an international financial services group where he independently managed large projects and technical developments, particularly in the area of motorsports.

Mr. Schneider was also the CFO and managing director of group companies.

Martin Schneider is a graduate of TGM Vienna with a major in mechanical engineering and has specialized in project management for many years.

He possesses extensive experience in international financial and organizational management.

In recent years he held leading positions at an international financial services group where he independently managed large projects and technical developments, particularly in the area of motorsports.

Mr. Schneider was also the CFO and managing director of group companies.

Certified Engineer
Susana Neudl studied biomedical engineering at TU Vienna.

She wrote her dissertation at the Physical Chemical Institute of TU Vienna on the primary factors in mechanical respiration,
whereby she developed a new algorithm for calculating flow behavior in the air passages of spontaneous respiration and mechanical respiration of both healthy and damaged lungs.

Ms. Neudl has been with the company since its inception and made major contributions to the development of the LiquiClear platform technology.

She leads technical development of prototypes, coordinates collaboration with TU Vienna, and is responsible for management of our laboratory.

Certified Engineer
Mr. Janeczek studied mechanical engineering at TU Vienna with a focus on “biomechanical engineering”.

He is currently finishing his doctoral degree in technical sciences of mechanical engineering.

Christoph Janeczek is responsible for developing the intracorporeal catheter drive, particularly the blood pump as a means of conveyance for elevating pressure in the catheter, as well as integration of the drive in the catheter design.

Certified Engineer
Martin Elenkov completed the interdisciplinary course of study in biomedical engineering at TU Vienna.

During his doctoral studies he was involved in the development of a liquid lung.

In our project, Martin Elenkov is responsible for developing estimation and control algorithms of CO<Subscript>2</Subscript> regulation in the blood and for designing test systems with sensors.

Additionally, he is responsible for programming microregulators and development of GUI applications in Lab View and Python.

Marek Lanc defended his PhD thesis aimed to gas transport in modern membrane materials at the Department of Physical Chemistry, University of Chemistry and Technology in Prague. His experience is mainly in dense membrane transport phenomena, membrane characterization and preparation.
In our team, he will be responsible for the membrane development, evaluation of overall solutions and expert advice to the project management.

Certified Engineer
Susana Neudl studied biomedical engineering at TU Vienna.

She wrote her dissertation at the Physical Chemical Institute of TU Vienna on the primary factors in mechanical respiration,
whereby she developed a new algorithm for calculating flow behavior in the air passages of spontaneous respiration and mechanical respiration of both healthy and damaged lungs.

Ms. Neudl has been with the company since its inception and made major contributions to the development of the LiquiClear platform technology.

She leads technical development of prototypes, coordinates collaboration with TU Vienna, and is responsible for management of our laboratory.

Certified Engineer
Mr. Janeczek studied mechanical engineering at TU Vienna with a focus on “biomechanical engineering”.

He is currently finishing his doctoral degree in technical sciences of mechanical engineering.

Christoph Janeczek is responsible for developing the intracorporeal catheter drive, particularly the blood pump as a means of conveyance for elevating pressure in the catheter, as well as integration of the drive in the catheter design.

Certified Engineer
Martin Elenkov completed the interdisciplinary course of study in biomedical engineering at TU Vienna.

During his doctoral studies he was involved in the development of a liquid lung.

In our project, Martin Elenkov is responsible for developing estimation and control algorithms of CO<Subscript>2</Subscript> regulation in the blood and for designing test systems with sensors.

Additionally, he is responsible for programming microregulators and development of GUI applications in Lab View and Python.

Marek Lanc defended his PhD thesis aimed to gas transport in modern membrane materials at the Department of Physical Chemistry, University of Chemistry and Technology in Prague. His experience is mainly in dense membrane transport phenomena, membrane characterization and preparation.
In our team, he will be responsible for the membrane development, evaluation of overall solutions and expert advice to the project management.